dc.contributor.author | Yetik, Huseyin | |
dc.date.accessioned | 2021-03-03T18:16:45Z | |
dc.date.available | 2021-03-03T18:16:45Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Yetik H., "Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9)", OPHTHALMOLOGY, cilt.122, sa.8, 2015 | |
dc.identifier.issn | 0161-6420 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_4e2a8691-6068-4ff9-9a38-64abdf8a4b05 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/55843 | |
dc.identifier.uri | https://doi.org/10.1016/j.ophtha.2014.11.031 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Göz Hastalıkları ve Cerrahisi | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | OFTALMOLOJİ | |
dc.title | Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9) | |
dc.type | Makale | |
dc.relation.journal | OPHTHALMOLOGY | |
dc.contributor.department | İstanbul Üniversitesi , Cerrahpaşa Tıp Fakültesi , Cerrahi Tıp Bilimleri | |
dc.identifier.volume | 122 | |
dc.identifier.issue | 8 | |
dc.contributor.firstauthorID | 223732 | |